These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11983003)

  • 1. Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers.
    Cullen B; Smith R; McCulloch E; Silcock D; Morrison L
    Wound Repair Regen; 2002; 10(1):16-25. PubMed ID: 11983003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors.
    Trengove NJ; Stacey MC; MacAuley S; Bennett N; Gibson J; Burslem F; Murphy G; Schultz G
    Wound Repair Regen; 1999; 7(6):442-52. PubMed ID: 10633003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological wound matrices with native dermis-like collagen efficiently modulate protease activity.
    Tati R; Nordin S; Abdillahi SM; Mörgelin M
    J Wound Care; 2018 Apr; 27(4):199-209. PubMed ID: 29637827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing.
    Lobmann R; Zemlin C; Motzkau M; Reschke K; Lehnert H
    J Diabetes Complications; 2006; 20(5):329-35. PubMed ID: 16949521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of oxidised regenerated cellulose/collagen in chronic wound repair and its potential mechanism of action.
    Cullen B; Watt PW; Lundqvist C; Silcock D; Schmidt RJ; Bogan D; Light ND
    Int J Biochem Cell Biol; 2002 Dec; 34(12):1544-56. PubMed ID: 12379277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oxidized regenerated cellulose/collagen matrix on proteases in wound exudate of patients with diabetic foot ulcers.
    Ulrich D; Smeets R; Unglaub F; Wöltje M; Pallua N
    J Wound Ostomy Continence Nurs; 2011; 38(5):522-8. PubMed ID: 21860331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-healing foot ulcers in diabetic patients: general and local interfering conditions and management options with advanced wound dressings.
    Uccioli L; Izzo V; Meloni M; Vainieri E; Ruotolo V; Giurato L
    J Wound Care; 2015 Apr; 24(4 Suppl):35-42. PubMed ID: 25853647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing Elevated Protease Activity: Prospective Analysis of 160 Wounds.
    Lockmann A; Schill T; Hartmann F; Grönemeyer LL; Holzkamp R; Schön MP; Thoms KM
    Adv Skin Wound Care; 2018 Feb; 31(2):82-88. PubMed ID: 29346149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers.
    Veves A; Sheehan P; Pham HT
    Arch Surg; 2002 Jul; 137(7):822-7. PubMed ID: 12093340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foot ulcers. A prospective randomized trial.
    Kakagia DD; Kazakos KJ; Xarchas KC; Karanikas M; Georgiadis GS; Tripsiannis G; Manolas C
    J Diabetes Complications; 2007; 21(6):387-91. PubMed ID: 17967712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing.
    Muller M; Trocme C; Lardy B; Morel F; Halimi S; Benhamou PY
    Diabet Med; 2008 Apr; 25(4):419-26. PubMed ID: 18387077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of endogenous and exogenous enzymes in chronic wounds: a focus on the implications of aberrant levels of both host and bacterial proteases in wound healing.
    McCarty SM; Cochrane CA; Clegg PD; Percival SL
    Wound Repair Regen; 2012; 20(2):125-36. PubMed ID: 22380687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified cotton gauze dressings that selectively absorb neutrophil elastase activity in solution.
    Edwards JV; Yager DR; Cohen IK; Diegelmann RF; Montante S; Bertoniere N; Bopp AF
    Wound Repair Regen; 2001; 9(1):50-8. PubMed ID: 11350640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining a new diagnostic assessment parameter for wound care: Elevated protease activity, an indicator of nonhealing, for targeted protease-modulating treatment.
    Serena TE; Cullen BM; Bayliff SW; Gibson MC; Carter MJ; Chen L; Yaakov RA; Samies J; Sabo M; DeMarco D; Le N; Galbraith J
    Wound Repair Regen; 2016 May; 24(3):589-95. PubMed ID: 27027492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human neutrophil elastase and collagenase sequestration with phosphorylated cotton wound dressings.
    Edwards JV; Howley PS
    J Biomed Mater Res A; 2007 Nov; 83(2):446-54. PubMed ID: 17477392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective and randomised evaluation of the protease-modulating effect of oxidised regenerated cellulose/collagen matrix treatment in pressure sore ulcers.
    Kloeters O; Unglaub F; de Laat E; van Abeelen M; Ulrich D
    Int Wound J; 2016 Dec; 13(6):1231-1236. PubMed ID: 26011241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of matrix-metalloproteases in the fluid of chronic diabetic foot wounds treated with a protease absorbent dressing.
    Motzkau M; Tautenhahn J; Lehnert H; Lobmann R
    Exp Clin Endocrinol Diabetes; 2011 May; 119(5):286-90. PubMed ID: 21031342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers.
    Ladwig GP; Robson MC; Liu R; Kuhn MA; Muir DF; Schultz GS
    Wound Repair Regen; 2002; 10(1):26-37. PubMed ID: 11983004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients.
    Lobmann R; Ambrosch A; Schultz G; Waldmann K; Schiweck S; Lehnert H
    Diabetologia; 2002 Jul; 45(7):1011-6. PubMed ID: 12136400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer.
    Rayment EA; Upton Z; Shooter GK
    Br J Dermatol; 2008 May; 158(5):951-61. PubMed ID: 18284390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.